As potent factors of tumor angiogenesis, HIF-1α and VEGF play important roles in the development, progression, and metastasis of HCC and are important for the efficacy evaluation of TACE of HCC patients and the development of individualized treatment regimens. The gene discussed is VEGFA; the disease is neoplasm.